15th Annual 2022 Women Tech Award Recipients
The Women’s Tech Council announced eight award recipients from its twenty one finalists. […]
The Women’s Tech Council announced eight award recipients from its twenty one finalists. […]
Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development of their secure, decentralized platform. […]
SINTX announces the receipt of a Phase II award of $1.1M, issued by the U.S. Department of Energy (DOE) to develop, design and characterize 3D-printed alumina ceramic heat exchangers for heating, ventilation, and air conditioning systems (HVAC). […]
SINTX announced a Phase I grant of $275k awarded by the National Institutes of Health (NIH) to develop and test an antimicrobial trauma device. […]
CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations […]
Foldax announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday. […]
Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system underscore value of KidneyIntelX™ platform in improving cost economics for Medicare population. […]
Attendance at premiere medical technology convention to spur partnership, growth opportunities. SALT LAKE CITY, October 10, 2022 /PRNewswire/ – EVŌQ Bio (an EVŌQ Nano company), a nano-platform technology company, is pleased to announce their attendance at the MedTech Conference 2022 in Boston, Massachusetts October 24-26, 2022. The MedTech Conference is the premiere venue for executives […]
LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (NYSE: OWLT) (the “Company”) announces that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (“FDA”) for a new prescription monitoring device for infants. The Company’s device, which uses pulse oximetry technology, is intended to be prescribed by physicians for assisting with the in-home monitoring […]
Woods Cross, UT (October 6, 2022) – Phoenix PharmaLabs, Inc. (https://phoenixpharmalabs.com), a private company developing potent, non-addictive treatments for pain and addiction, today announced the receipt of an $8.7 million grant from the National Institute on Drug Abuse (NIDA). The primary focus of the grant is to study the company’s lead compound, PPL-138, for the […]
Xenter unveiled XenFI™, the first product in its wireless “Technology in Medicine” ecosystem. […]
Completion of Trial is a Sign of Things to Come for Novel Embolic Agent […]